Skip to Content

POTTERS ECZEMA OINTMENT

PDF options:  View Fullscreen   Download PDF

PDF Transcript

SUMMARY OF PRODUCT CHARACTERISTICS

1

NAME OF THE MEDICINAL PRODUCT
Potter’s Eczema Ointment

2

QUALITATIVE AND QUANTITATIVE COMPOSITION
Zinc Oxide BP 8.7 % w/w; Salicylic Acid BP 2.0 % w/w; Benzoic Acid BP
0.23 % w/w; Soft Extract Chickweed 100=42 6.3 % w/w

3

PHARMACEUTICAL FORM
Ointment

4

CLINICAL PARTICULARS

4.1

Therapeutic indications
For the symptomatic relief of eczema.

4.2

Posology and method of administration
Adults, Elderly and Children over 5: Apply twice daily to the areas affected.
Not for children under 5.

4.3

Contraindications
None.

4.4

Special warnings and precautions for use
Remove jewellery.
Keep medicines away from children.

4.5

Interaction with other medicinal products and other forms of interaction
None known.

4.6

Fertility, Pregnancy and lactation
Not recommended.

4.7

Effects on ability to drive and use machines
None.

4.8

Undesirable effects
None.

4.9

Overdose
No cases known.

5

PHARMACOLOGICAL PROPERTIES

5.1

Pharmacodynamic properties
Zinc Oxide is astringent. Salicylic and Benzoic Acids are keratolytic.
Chickweed extract is emollient.

5.2

Pharmacokinetic properties
No information available.

5.3

Preclinical safety data
No information available.

6

PHARMACEUTICAL PARTICULARS

6.1

List of excipients
Hydrous Lanolin, Vanillin, Lard, Yellow Soft Paraffin.

6.2

Incompatibilities
None.

6.3

Shelf life
Three years.

6.4

Special precautions for storage
None.

6.5

Nature and contents of container
Double-wall polyethylene pot with hard plastic screwcap: 28 g.

Glass jar with hard plastic screwcap: 28 g.
Hard plastic jar with hard plastic screwoap: 500 g.

6.6

Special precautions for disposal
Not applicable.

7

MARKETING AUTHORISATION HOLDER
Vifor Pharma UK Ltd
1 Botanic Court,
Martland Park,
Wigan,
WN5 0JZ,
UK.
Trading as: Potters, Wigan WN5 0JZ

8

MARKETING AUTHORISATION NUMBER(S)
PL 33656/0010

9

DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
31/08/1984 / 27/03/2003

10

DATE OF REVISION OF THE TEXT
14/07/2012

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide